Effect of Sinetrol® Xpur on metabolic health and adiposity by interactions with gut microbiota: a randomized, open label, dose–response clinical trial
Overall chronic supplementation of Sinetrol<sup>®</sup> Xpur, irrespective of their dose improved HDL, HbA1c, LDL and leptin and tended to decrease visceral adipose tissue via changes in gut microbiota. Trial registration number NCT03823196.
Authors
- Cindy Romain (ORCID: https://orcid.org/0000-0002-3922-8438)
- Francisco Javier Martínez-Noguera (ORCID: https://orcid.org/0000-0002-2851-9029)
- Linda H. Chung (ORCID: https://orcid.org/0000-0001-5899-9097)
- Jananee Muralidharan (ORCID: https://orcid.org/0000-0002-2889-1007)
- Pedro E. Alcaráz (ORCID: https://orcid.org/0000-0002-9792-6656)
- Mayoura Kéophiphath (ORCID: https://orcid.org/0000-0002-8388-2189)
- Julien Cases (ORCID: https://orcid.org/0000-0002-6368-250X)
- Benjamin Lelouvier (ORCID: https://orcid.org/0000-0002-8710-6777)
- Bénédicte Gaborit (ORCID: https://orcid.org/0000-0002-4180-158X)
- Patricia Ancel
Institutions
- European Union Agency for Law Enforcement Cooperation (NL)
- Inserm (FR)
- Aix-Marseille Université (FR)
- Compagnie Maritime d'Expertises (France) (FR)
- Universidad Católica de Murcia (ES)
Publication Details
- Journal
- Nutrition & Metabolism
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1186/s12986-024-00851-7
- Citations
- 4
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.94